| Device Classification Name |
Next Generation Sequencing Based Tumor Profiling Test
|
| 510(k) Number |
K241868 |
| Device Name |
xR IVD |
| Applicant |
| Tempus AI, Inc. |
| 600 W Chicago Ave. |
| Suite #510 |
|
Chicago,
IL
60654
|
|
| Applicant Contact |
Sarah Piloto |
| Correspondent |
| Tempus AI, Inc. |
| 600 W Chicago Ave. |
| Suite #510 |
|
Chicago,
IL
60654
|
|
| Correspondent Contact |
Sarah Piloto |
| Regulation Number | 866.6080 |
| Classification Product Code |
|
| Date Received | 06/27/2024 |
| Decision Date | 09/19/2025 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Pathology
|
| 510k Review Panel |
Pathology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|